RESUMEN
BACKGROUND: Human apocrine (epitrichial) sweat glands secrete in response to local or systemic administration of catecholamines and cholinergic agonists. As the process of secretion in human apocrine glands is not fully understood and no literature detailing the expression of adrenergic, cholinergic and purinergic receptors is available, there is a need to know the receptor types. Such data could provide new approaches for the treatment of axillary bromhidrosis. OBJECTIVES: To investigate the localization of nerve fibres, adrenergic, cholinergic and purinergic receptors in human axillary apocrine sweat glands by immunohistochemistry. METHODS: Human axillary apocrine sweat glands were investigated by serial sectioning of paraffin wax-embedded skin samples from volunteers. Sections were examined by light microscopy and immunohistochemistry, using antibodies against neurofilament, alpha- and beta-adrenoceptors, P2Y(1), P2Y(2) and P2Y(4) purinoceptors, and M(3) cholinoceptors. RESULTS: Neurofilaments were found near the eccrine but not the apocrine gland. Apocrine glands demonstrated the presence of beta-2 and beta-3 adrenoceptors in the secretory coil of the gland, but not alpha-1, beta-1 or M(3) receptors. Glandular purinergic staining (P2Y(1), P2Y(2) and P2Y(4)) was found in what looked like myoepithelial cells, while P2Y(1) and P2Y(2) staining was found on apical membranes and diffusely throughout secretory cells. Eccrine gland staining acted as internal positive controls. CONCLUSIONS: No nerve fibres were found near the apocrine gland, suggesting that any catecholamine influence is through humoral effects and that glands could be influenced by beta-adrenoceptor subtypes and purinoceptors. Blockage of both these types of receptors offers a route to controlling apocrine secretion from axillary glands and reducing the opportunity for the development of bromhidrosis.
Asunto(s)
Glándulas Apocrinas/inervación , Glándulas Apocrinas/metabolismo , Proteínas de Neurofilamentos/análisis , Receptor Muscarínico M3/análisis , Receptores Adrenérgicos/análisis , Receptores Purinérgicos/análisis , Adulto , Axila , Biomarcadores/análisis , Femenino , Humanos , Hiperhidrosis/tratamiento farmacológico , Hiperhidrosis/metabolismo , Hiperhidrosis/fisiopatología , Inmunohistoquímica , Masculino , Receptores Adrenérgicos alfa 1/análisis , Receptores Adrenérgicos beta 1/análisis , Receptores Adrenérgicos beta 2/análisis , Receptores Adrenérgicos beta 3/análisis , Receptores Purinérgicos P2/análisis , Receptores Purinérgicos P2Y1 , Receptores Purinérgicos P2Y2 , Coloración y EtiquetadoRESUMEN
The localisation of the vacuolar proton pump (V-H+ -ATPase) and the enzyme carbonic anhydrase II (CAII) was investigated in the human eccrine sweat gland employing standard immunohistochemical techniques after antigen retrieval using microwave heat treatment and high pressure. The high-pressure antigen retrieval unmasked the presence of V-H+ -ATPase in the clear cells of the secretory coil, with a distribution similar to that previously observed for CAII. However, the dark cells were unreactive to both antibodies. In addition, heat and high-pressure antigen retrieval demonstrated the presence of CAII in the apical zone of luminal cells of the reabsorptive duct, a location not previously reported. The localisation of V-H+ -ATPase and CAII in the secretory coil clear cells suggests that the formation of HCO3- and H+ by carbonic anhydrase II and the transport of H+ by V-H+ -ATPase may play an role in sweat fluid secretion. Their presence at the apex of the duct cells indicates involvement in ductal ion reabsorption.
Asunto(s)
Glándulas Ecrinas/metabolismo , Piel/metabolismo , ATPasas de Translocación de Protón Vacuolares/metabolismo , Glándulas Ecrinas/citología , Humanos , Inmunohistoquímica , Piel/anatomía & histologíaRESUMEN
We have examined the hypothesis that intrathecal fentanyl at operation can increase postoperative i.v. morphine requirements. We studied 60 patients undergoing Caesarean section. All received intrathecal 0.5% plain bupivacaine 2 ml combined with either fentanyl 0.5 ml (25 micrograms) (group F) (n = 30) or normal saline 0.5 ml (group S) (n = 30). In addition, 10 ml of an extradural solution (fentanyl 1 ml (50 micrograms) combined with 0.5% bupivacaine 9 ml) was administered after delivery. Extradural solution was only given before delivery if the intrathecal injection failed to produce a block above T6 or the patient required further analgesia. Postoperative analgesia was provided with i.v. morphine patient-controlled analgesia. At operation, intrathecal fentanyl reduced the need to administer extradural solution before delivery, increased the anaesthetist's satisfaction with analgesia and reduced nausea, but increased pruritus. Up to 6 h after delivery there was no difference in postoperative morphine requirements or pain scores. Between 6 h and 23 h there was a 63% increase in morphine requirements in group F. We consider the most likely explanation for this finding to be that intrathecal fentanyl induced acute spinal opioid tolerance.
Asunto(s)
Analgésicos Opioides/farmacología , Anestesia Obstétrica , Anestesia Raquidea , Fentanilo/farmacología , Morfina/farmacología , Analgesia Controlada por el Paciente , Cesárea , Método Doble Ciego , Esquema de Medicación , Tolerancia a Medicamentos , Femenino , Humanos , Dolor Postoperatorio/tratamiento farmacológico , EmbarazoRESUMEN
In this randomized, double-blind study of 60 patients, we have assessed the analgesic efficacy of extradural bupivacaine and extradural fentanyl, either alone or in combination, after Caesarean section. Patients received 0.1% bupivacaine (group B), fentanyl 4 micrograms ml-1 (group F) or 0.05% bupivacaine combined with fentanyl 2 micrograms ml-1 (group BF) by patient-controlled extradural analgesia (PCEA). Adding fentanyl to bupivacaine reduced the dose of bupivacaine by up to 68%, improved analgesia at rest and decreased PCEA use. Motor and sensory block were decreased, but there was more pruritus. Overall patient satisfaction was increased. Adding bupivacaine to fentanyl reduced the dose of fentanyl by up to 57% without altering pain scores or PCEA use. Sensory block increased but pruritus did not decrease. Bupivacaine 0.05% produced clinically significant leg weakness in three patients. Overall patient satisfaction was not altered. There was a significant additive analgesic effect between 0.05% bupivacaine and fentanyl but no clinical benefit was demonstrated from using the combination compared with fentanyl alone for this group of postoperative patients.
Asunto(s)
Analgesia Epidural , Analgesia Controlada por el Paciente , Analgésicos Opioides , Anestésicos Locales , Bupivacaína , Cesárea , Fentanilo , Dolor Postoperatorio/prevención & control , Adulto , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Satisfacción del Paciente , Embarazo , Factores de Tiempo , Resultado del TratamientoRESUMEN
Minimum alveolar concentration (MAC) for halothane was measured before and after administration of intravenous butorphanol (0.022 and 0.044 mg/kg in bodyweight in nine yearling Shetland ponies. Arterial blood pressure, heart rate, respiratory rate, expired CO2 and rectal temperature was also measured. Even though mean MAC values decreased 10 and 9 per cent after the low and high doses respectively, they were not statistically different from those measured prior to butorphanol. Halothane MAC values increased after butorphanol in two ponies, both animals increasing locomotor activity and demonstrating apparent central nervous system stimulation. No significant differences were seen in any variable measured after butorphanol administration.
Asunto(s)
Anestesia/veterinaria , Butorfanol/farmacología , Halotano/farmacocinética , Caballos/metabolismo , Alveolos Pulmonares/metabolismo , Animales , Presión Sanguínea/efectos de los fármacos , Dióxido de Carbono/sangre , Interacciones Farmacológicas , Femenino , Concentración de Iones de Hidrógeno , Masculino , Oxígeno/sangreRESUMEN
The changes in intra-ocular pressure associated with two different anaesthetic induction and tracheal intubation techniques were compared (n = 30). After pre-oxygenation, Group A received thiopentone (5 mg/kg) followed by suxamethonium (1.5 mg/kg), both within 25 seconds, and Group B atracurium (0.5 mg/kg) followed by thiopentone (5 mg/kg) again both within 25 seconds. Tracheal intubation occurred after one minute in Group A and 2 minutes in Group B to allow for full paralysis. In Group A intra-ocular pressure did not alter significantly from baseline and the maximum increase was only 0.93 mmHg. The statistical type II error risk was consistently below 55% and all 95% confidence limits included negative values. Intra-ocular pressure in Group B was consistently lower than baseline (p less than 0.05) but with a longer induction-intubation interval. These results therefore provide valuable information about the 'balance of risks' when choosing a muscle relaxant for an inadequately starved patient with a penetrating eye injury.
Asunto(s)
Anestesia Intravenosa , Atracurio/farmacología , Presión Intraocular/efectos de los fármacos , Succinilcolina/farmacología , Tiopental/farmacología , Adolescente , Adulto , Anciano , Humanos , Intubación Intratraqueal , Persona de Mediana Edad , Estadística como Asunto , Factores de TiempoRESUMEN
This case study emphasises the multiple factors that may be involved in the precipitation of electromechanical dissociation, which are compounded by additional problems that relate to pregnancy. It reinforces the value of the tracheal route for drug administration when a central vein is not cannulated and stresses the importance of posture and early consideration of Caesarean section in the pre-term gravid patient who has sustained a cardiac arrest.
Asunto(s)
Paro Cardíaco/terapia , Complicaciones Cardiovasculares del Embarazo/terapia , Adolescente , Cuidados Críticos , Femenino , Humanos , Embarazo , Tercer Trimestre del Embarazo , Resucitación/métodosRESUMEN
Local abscess formation, septicaemia and median nerve palsy occurred as complications of radial artery cannulation in a 24-year-old man with malaria. The case is described and the nosocomial infection hazard of arterial cannulation is discussed.